Access to novel therapies for COVID-19 – distributive justice and Russian roulette?

M S Pepper



Author's affiliations

M S Pepper, Institute for Cellular and Molecular Medicine, Department of Immunology; SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, South Africa

Full Text

PDF (68KB)


COVID-19; Therapy; Access; Experimental treatments

Cite this article

South African Medical Journal 2020;110(12):1156-1157. DOI:10.7196/SAMJ.2020.v110i12.15362

Article History

Date submitted: 2020-10-13
Date published: 2020-10-13

Article Views

Abstract views: 2599
Full text views: 793

Comments on this article

*Read our policy for posting comments here